Behring Institute Mitteilungen最新文献

筛选
英文 中文
Biology of natural and recombinant soluble interleukin-4 receptor. 天然和重组可溶性白介素-4受体生物学。
Behring Institute Mitteilungen Pub Date : 1995-06-01
K Enssle, B Enders, R Kurrle, L Lauffer, H U Schorlemmer, G Dickneite, E J Kanzy, F R Seiler
{"title":"Biology of natural and recombinant soluble interleukin-4 receptor.","authors":"K Enssle, B Enders, R Kurrle, L Lauffer, H U Schorlemmer, G Dickneite, E J Kanzy, F R Seiler","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 96","pages":"103-17"},"PeriodicalIF":0.0,"publicationDate":"1995-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18582414","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS. APO-1/Fas(CD95)介导的细胞凋亡在耐受性和艾滋病中的分子机制。
Behring Institute Mitteilungen Pub Date : 1995-06-01
J Dhein, H Walczak, M O Westendorp, C Bäumler, K Stricker, R Frank, K M Debatin, P H Krammer
{"title":"Molecular mechanisms of APO-1/Fas(CD95)-mediated apoptosis in tolerance and AIDS.","authors":"J Dhein,&nbsp;H Walczak,&nbsp;M O Westendorp,&nbsp;C Bäumler,&nbsp;K Stricker,&nbsp;R Frank,&nbsp;K M Debatin,&nbsp;P H Krammer","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>The cell surface molecule APO-1/Fas(CD95), a member of the Tumor Necrosis Factor (TNF) receptor/Nerve Growth Factor (NGF) receptor superfamily mediates apoptosis upon cross-linking by agonistic antibodies or its ligand. Recent findings suggest that APO-1/Fas(CD95) and its ligand are the key molecules for antigen receptor-induced apoptosis in activated mature T cells. Here we propose a mechanism for antigen receptor-induced apoptosis of activated T cells via APO-1 ligand mediated autocrine suicide. This mechanism may also contribute to the depletion of CD4+ T cells in AIDS.</p>","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 96","pages":"13-20"},"PeriodicalIF":0.0,"publicationDate":"1995-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18582416","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Converging and diverging properties of human interleukin-4 and interleukin-10. 人白细胞介素-4和白细胞介素-10的收敛和发散特性。
Behring Institute Mitteilungen Pub Date : 1995-06-01
J Banchereau
{"title":"Converging and diverging properties of human interleukin-4 and interleukin-10.","authors":"J Banchereau","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>IL-4 and IL-10 are both produced by activated TH2 cells as well as basophil/mast cells. In addition, IL-10 is secreted by activated B cells, monocytes/macrophages and keratinocytes. IL-4 and IL-10 act in concert to induce activated B lymphocytes to grow, switch isotype and ultimately differentiate into antibody producing plasma cells. Both IL-4 and IL-10 inhibit the secretion of proinflammatory cytokines by monocytes/macrophages and neutrophils. While IL-4 enhances the presentation of antigen by monocytes/macrophages and dendritic cells, IL-10 inhibits it. IL-4 and IL-10 can either stimulate or inhibit T cell proliferation. While both cytokines may prove useful in the management of inflammatory disorders, IL-4 is presently used in clinical trials that relate to its antitumor effects.</p>","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 96","pages":"58-77"},"PeriodicalIF":0.0,"publicationDate":"1995-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18581094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antagonistic mutant proteins of interleukin-4. 白细胞介素-4的拮抗突变蛋白。
Behring Institute Mitteilungen Pub Date : 1995-06-01
A Duschl, T Müller, W Sebald
{"title":"Antagonistic mutant proteins of interleukin-4.","authors":"A Duschl,&nbsp;T Müller,&nbsp;W Sebald","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Interleukin-4 is a major regulator of the immune system, directing e.g. induction of a TH2 phenotype in T-cells, activation of B-cells and synthesis of IgE type antibodies, which are associated with allergic responses. Site-directed mutagenesis has revealed two sites important for receptor interaction on IL-4: site I mediates binding to the IL-4 receptor alpha subunit, and site II is involved in signal transduction through the receptor complex. Specific mutations in site II produced a series of ligands which bound to the receptor with high affinity, but had little or no agonistic activity and inhibited effects of wild type IL-4. The closely related cytokine IL-13, also a mediator of allergic processes, is antagonized as well. Antagonistic site II mutants of human IL-4 are therefore effective inhibitors with therapeutic potential for IL-4 associated diseases like type I hypersensitivity and asthma.</p>","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 96","pages":"87-94"},"PeriodicalIF":0.0,"publicationDate":"1995-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18581097","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Replication-incompetent adenoviruses as vectors for protective immunization against measles virus infection. 无复制能力腺病毒作为麻疹病毒感染保护性免疫的载体。
Behring Institute Mitteilungen Pub Date : 1994-12-01
C Schindler, A Fooks, J Stephenson, U G Liebert
{"title":"Replication-incompetent adenoviruses as vectors for protective immunization against measles virus infection.","authors":"C Schindler,&nbsp;A Fooks,&nbsp;J Stephenson,&nbsp;U G Liebert","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>Despite the availability of an efficient live-attenuated measles virus vaccine about 1.5 million annual deaths from measles infections and their complications are recorded worldwide. Particularly in developing countries measles remains an unsolved problem and a new vaccine seems necessary. In our animal model of measles virus infection in rats we studied a candidate vaccine based on infectious replication incompetent (E1A-) adenovirus (RAd) where measles virus genes are expressed under the control of the cytomegalovirus immediate early promoter. The aim of the study was to characterize the cell mediated and humoral immunity after immunization with RAd and its protective effect. After challenge with a lethal dose of measles virus no signs of disease or histopathological changes were detected in RAd68-immunized rats. The elimination of measles virus was successful within a few days. The results demonstrate that defective recombinant adenovirus vectors can induce complete protection from experimental measles infection in rats.</p>","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 95","pages":"109-15"},"PeriodicalIF":0.0,"publicationDate":"1994-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18756008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vaccination strategies using viable carrier systems against intracellular pathogens. 利用活载体系统对抗细胞内病原体的疫苗接种策略。
Behring Institute Mitteilungen Pub Date : 1994-12-01
J Hess, G Szalay, D Miko, I Gentschev, W Goebel, C H Ladel, S H Kaufmann
{"title":"Vaccination strategies using viable carrier systems against intracellular pathogens.","authors":"J Hess,&nbsp;G Szalay,&nbsp;D Miko,&nbsp;I Gentschev,&nbsp;W Goebel,&nbsp;C H Ladel,&nbsp;S H Kaufmann","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 95","pages":"67-79"},"PeriodicalIF":0.0,"publicationDate":"1994-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18759140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA. 人恶性疟原虫血期抗原Pf155/RESA诱导的调节性t细胞反应的表征
Behring Institute Mitteilungen Pub Date : 1994-12-01
M Troye-Blomberg, O Olerup, H Perlmann, A Larsson, G Elghazali, A Fogdell, A Jepsen, J P Lepers, J P Pandey, J Grunewald
{"title":"Characterization of regulatory T-cell responses in humans induced by the P. Falciparum blood stage antigen Pf155/RESA.","authors":"M Troye-Blomberg,&nbsp;O Olerup,&nbsp;H Perlmann,&nbsp;A Larsson,&nbsp;G Elghazali,&nbsp;A Fogdell,&nbsp;A Jepsen,&nbsp;J P Lepers,&nbsp;J P Pandey,&nbsp;J Grunewald","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>T-cells have a major role both as helper cells for efficient antibody production and as inducers and effector cells in antibody-independent malaria immunity. Thus, antigens to be included into a subunit vaccine must contain T-cell epitopes to become effectively immunogenic. The P. falciparum blood stage vaccine antigen Pf155/RESA has been shown to contain T-helper epitopes inducing T-dependent anti-malarial antibodies in vitro. We have also shown that synthetic peptides representing sequences from the amino-acid repeat regions of Pf155/RESA stimulate T-cells from P. falciparum primed donors to proliferate, to release IFN-gamma and/or IL-4. In individual donors there was no correlation between these different activities. Rather, they were frequently negatively associated. However, IL-4 secretion could be induced in T-cells from donors who had elevated concentrations of serum antibodies to the same peptide as used for T-cell activation. Taken together the results support the occurrence of malaria-specific CD4+ T-cell subsets (e.g. TH1 and TH2) in humans similar to what has been found in mice and suggest the involvement of TH2-type helper cells in the induction of some important P. falciparum specific antibodies. CD4+ T-cells recognize the antigen in the context of MHC class II molecules. However, in human outbred populations no consistent MHC restrictions of anti-Pf155/RESA immune responses could be demonstrated. This is not surprising in view of the extensive polymorphism of the HLA system. Neither were there any obvious MHC class II restrictions seen when antibody- and t-cell responses were measured in naturally primed monozygotic twins.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 95","pages":"97-105"},"PeriodicalIF":0.0,"publicationDate":"1994-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18759142","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification of T-cell epitopes using allele-specific ligand motifs. 利用等位基因特异性配体基序鉴定t细胞表位。
Behring Institute Mitteilungen Pub Date : 1994-12-01
S Stevanović, H G Rammensee
{"title":"Identification of T-cell epitopes using allele-specific ligand motifs.","authors":"S Stevanović,&nbsp;H G Rammensee","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>In order to facilitate the identification of T-cell epitopes as useful components of synthetic vaccines, we investigated the role of MHC molecules as the restriction element for the recognition of epitopes by the alpha beta receptor of T cells. MHC molecules are able to present thousands of different peptides to T cells, with all the peptides presented by one distinct type of MHC sharing common structural features. Our group analyzed these common characteristics concerning peptide length (only MHC I ligands) and anchor positions (MHC I and II ligands) occupied by a small set of closely related amino acids. Until now, for more than fifty MHC proteins allele-specific \"peptide motifs\" have been defined. The exact knowledge of MHC I peptide motifs allows for a prediction of CTL epitopes, and this kind of prediction has been successful in many cases over the last three years.</p>","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 95","pages":"7-13"},"PeriodicalIF":0.0,"publicationDate":"1994-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18547114","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Synthesis and secretion of bacterial antigens by attenuated Salmonella via the Escherichia coli hemolysin secretion system. 减毒沙门氏菌通过大肠杆菌溶血素分泌系统合成和分泌细菌抗原。
Behring Institute Mitteilungen Pub Date : 1994-12-01
I Gentschev, H J Mollenkopf, Z Sokolovic, A Ludwig, C Tengel, R Gross, J Hess, A Demuth, W Goebel
{"title":"Synthesis and secretion of bacterial antigens by attenuated Salmonella via the Escherichia coli hemolysin secretion system.","authors":"I Gentschev,&nbsp;H J Mollenkopf,&nbsp;Z Sokolovic,&nbsp;A Ludwig,&nbsp;C Tengel,&nbsp;R Gross,&nbsp;J Hess,&nbsp;A Demuth,&nbsp;W Goebel","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>We describe a plasmid system which allows the secretion of foreign antigens in attenuated Salmonella aroA strains by the secretion apparatus of E. coli hemolysin. The gene (or gene fragment) encoding the antigen is inserted in frame into a residual position of the hlyA gene, encoding the HlyA secretion signal (HlyAs). Generally, the fused gene is efficiently expressed and the synthesized antigen is in part secreted into the culture supernatant and in part exposed on the surface of the producing Salmonella strain. The successful use of this approach is demonstrated with two antigens of Salmonella typhimurium, PagC and SlyA, both of which are potent virulence factors but produced only in small amounts under in vitro culture conditions and two virulence proteins of Listeria monocytogenes, p60 and listeriolysin. Interestingly the listeriolysin fusion protein proved to be cytolytically active and allowed, when expressed in Salmonella, the escape of these bacteria into the cytoplasm of infected macrophages.</p>","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 95","pages":"57-66"},"PeriodicalIF":0.0,"publicationDate":"1994-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18759139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Future Trends in Vaccine Development. Symposium proceedings. Ulm, July 15-16, 1994. 疫苗发展的未来趋势。研讨会论文集。1994年7月15日至16日,乌尔姆。
Behring Institute Mitteilungen Pub Date : 1994-12-01
{"title":"Future Trends in Vaccine Development. Symposium proceedings. Ulm, July 15-16, 1994.","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":8816,"journal":{"name":"Behring Institute Mitteilungen","volume":" 95","pages":"1-115"},"PeriodicalIF":0.0,"publicationDate":"1994-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18756005","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信